CVS Health (NYSE: CVS) reported Q3 EPS of $1.60, $0.23 better than the analyst estimate of $1.37. Revenue for the quarter came in at $102.9 billion versus the consensus estimate of $98.88 billion.

GUIDANCE:

CVS Health sees FY2025 EPS of $6.55-$6.65, versus the consensus of $6.38.

For earnings history and earnings-related data on CVS Health (CVS) click here.